Treatment Innovations

The Dawn of Precision Oncology: Inside the Merck-Moderna Personalized Cancer Vaccine Breakthrough

• Treatment Innovations

The Dawn of Precision Oncology: Inside the Merck-Moderna Personalized Cancer Vaccine Breakthrough

Laily UPN September 7, 2026

In a landmark shift for the field of oncology, a collaborative effort between pharmaceutical giant Merck &...

Read More Read more about The Dawn of Precision Oncology: Inside the Merck-Moderna Personalized Cancer Vaccine Breakthrough

AI Breakthrough in Cardiology: FDA Authorizes Powerful Medical’s ‘Queen of Hearts’ to Transform Heart Attack Detection

• Treatment Innovations

AI Breakthrough in Cardiology: FDA Authorizes Powerful Medical’s ‘Queen of Hearts’ to Transform Heart Attack Detection

Lina Hope September 7, 2026

The landscape of emergency cardiology in the United States is undergoing a seismic shift. The US Food...

Read More Read more about AI Breakthrough in Cardiology: FDA Authorizes Powerful Medical’s ‘Queen of Hearts’ to Transform Heart Attack Detection

Hamamatsu Photonics Expands Digital Pathology Footprint with FDA Clearance for NanoZoomer S20MD and S540MD

• Treatment Innovations

Hamamatsu Photonics Expands Digital Pathology Footprint with FDA Clearance for NanoZoomer S20MD and S540MD

Sagoh September 6, 2026

In a significant move for the digital pathology landscape, Hamamatsu Photonics has officially secured 510(k) clearance from...

Read More Read more about Hamamatsu Photonics Expands Digital Pathology Footprint with FDA Clearance for NanoZoomer S20MD and S540MD

The Lp(a) Paradox: Novartis and Ionis Face Setback as Landmark Pelacarsen Trial Fails to Move the Needle on Heart Health

• Treatment Innovations

The Lp(a) Paradox: Novartis and Ionis Face Setback as Landmark Pelacarsen Trial Fails to Move the Needle on Heart Health

Nana September 6, 2026

In a development that has sent shockwaves through the cardiovascular research community, Novartis and Ionis Pharmaceuticals announced...

Read More Read more about The Lp(a) Paradox: Novartis and Ionis Face Setback as Landmark Pelacarsen Trial Fails to Move the Needle on Heart Health

The Intravascular Lithotripsy Revolution: Reshaping the Landscape of Interventional Cardiology

• Treatment Innovations

The Intravascular Lithotripsy Revolution: Reshaping the Landscape of Interventional Cardiology

Rifan Muazin September 5, 2026

Introduction: A Paradigm Shift in Arterial Calcification For decades, the presence of severe arterial calcification—the hardening of...

Read More Read more about The Intravascular Lithotripsy Revolution: Reshaping the Landscape of Interventional Cardiology

Beyond Automation: The Paradigm Shift Toward AI-Assisted Decision Intelligence in Pharmacovigilance

• Treatment Innovations

Beyond Automation: The Paradigm Shift Toward AI-Assisted Decision Intelligence in Pharmacovigilance

Rifan Muazin September 5, 2026

In the high-stakes environment of pharmaceutical safety, the sheer volume of data is no longer just a...

Read More Read more about Beyond Automation: The Paradigm Shift Toward AI-Assisted Decision Intelligence in Pharmacovigilance

HR HealthCare Launches the ‘Liv’ Catheter: Redefining Hygiene and Autonomy in Women’s Bladder Health

• Treatment Innovations

HR HealthCare Launches the ‘Liv’ Catheter: Redefining Hygiene and Autonomy in Women’s Bladder Health

Pevita Pearce September 5, 2026

In an era where medical technology is increasingly focused on patient-centric design, US-based medical device manufacturer HR...

Read More Read more about HR HealthCare Launches the ‘Liv’ Catheter: Redefining Hygiene and Autonomy in Women’s Bladder Health

The Next Frontier: Evolution of the GLP-1 Landscape and the Future of Metabolic Medicine

• Treatment Innovations

The Next Frontier: Evolution of the GLP-1 Landscape and the Future of Metabolic Medicine

Basiran September 5, 2026

The global landscape for metabolic health is undergoing a seismic shift. For years, the pharmaceutical industry’s focus...

Read More Read more about The Next Frontier: Evolution of the GLP-1 Landscape and the Future of Metabolic Medicine

Strengthening the Frontline: Cepheid’s Diagnostic Tool Gains WHO Emergency Listing Amid Escalating Bundibugyo Ebola Crisis

• Treatment Innovations

Strengthening the Frontline: Cepheid’s Diagnostic Tool Gains WHO Emergency Listing Amid Escalating Bundibugyo Ebola Crisis

Asro September 5, 2026

Executive Summary In a significant development for the containment of the ongoing Bundibugyo ebolavirus (BVD) outbreak in...

Read More Read more about Strengthening the Frontline: Cepheid’s Diagnostic Tool Gains WHO Emergency Listing Amid Escalating Bundibugyo Ebola Crisis

Navigating the HRT Shortage: FDA Intervention and the Changing Landscape of Hormone Replacement Therapy

• Treatment Innovations

Navigating the HRT Shortage: FDA Intervention and the Changing Landscape of Hormone Replacement Therapy

Nana Muazin September 5, 2026

The United States is currently grappling with a significant supply chain bottleneck for transdermal estradiol patches, a...

Read More Read more about Navigating the HRT Shortage: FDA Intervention and the Changing Landscape of Hormone Replacement Therapy